Cargando…

Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients

Unlike solid-tumor patients, a disappointingly small subset of multiple myeloma (MM) patients treated with checkpoint inhibitors derive clinical benefits, suggesting differential participation of inhibitory receptors involved in the development of T-cell-mediated immunosuppression. In fact, T cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kulikowska de Nałęcz, Anna, Ciszak, Lidia, Usnarska-Zubkiewicz, Lidia, Frydecka, Irena, Pawlak, Edyta, Szmyrka, Magdalena, Kosmaczewska, Agata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431347/ https://www.ncbi.nlm.nih.gov/pubmed/34502204 http://dx.doi.org/10.3390/ijms22179298

Ejemplares similares

Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors
por: Kulikowska de Nałęcz, Anna, et al.
Publicado: (2023)

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody
por: Ciszak, Lidia, et al.
Publicado: (2015)

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia
por: Ciszak, Lidia, et al.
Publicado: (2015)

Exogenous IL-2 Controls the Balance in Th1, Th17, and Treg Cell Distribution in Patients with Progressive Rheumatoid Arthritis Treated with TNF-Alpha Inhibitors
por: Kosmaczewska, Agata, et al.
Publicado: (2014)

Alterations in Both the Activatory and Inhibitory Potential of Peripheral Blood CD4+ T Cells in Rheumatoid Arthritis Patients Correlate with Disease Progression
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
por: Karabon, L., et al.
Publicado: (2020)

Imbalance in PB IL-17-Secreting and Regulatory Cells in Pars Planitis Is Associated with Dysregulation of IFN-γ-Secreting Cells, Especially in Patients with Clinical Complications
por: Kosmaczewska, Agata, et al.
Publicado: (2020)

Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Related to Disease Progression
por: Kosmaczewska, Agata, et al.
Publicado: (2011)

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Bortezomib-induced painful neuropathy in patients with multiple myeloma
por: Bilińska, Małgorzata, et al.
Publicado: (2013)

Ascites in the Course of Plasma Cell Myeloma Complicated by AL Amyloidosis
por: Debski, Jakub, et al.
Publicado: (2018)

P980: THE ROLE OF PLATELET AND ENDOTHELIAL MICROPARTICLES AND DOPPLER ULTRASOUND SCREENING IN THE ASSESSMENT OF THROMBOTIC READINESS IN MULTIPLE MYELOMA AND NON HODGKIN LYMPHOMA, PROSPECTIVE STUDY
por: Olszewska-Szopa, Magdalena, et al.
Publicado: (2023)

The effect of peripheral blood lymphocyte stimulation on zeta chain expression and IL-2 production in Hodgkin's disease
por: Frydecka, I, et al.
Publicado: (2001)

Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population
por: Karabon, Lidia, et al.
Publicado: (2011)

Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia
por: Frydecka, I, et al.
Publicado: (2004)

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation
por: Karabon, Lidia, et al.
Publicado: (2015)

BTLA Expression in CLL: Epigenetic Regulation and Impact on CLL B Cell Proliferation and Ability to IL-4 Production
por: Karabon, Lidia, et al.
Publicado: (2021)

Bendamustine-Based Regimens as Salvage Therapy in Refractory/Relapsed Multiple Myeloma Patients: A Retrospective Real-Life Analysis by the Polish Myeloma Group
por: Grzasko, Norbert, et al.
Publicado: (2021)

Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma – results of a prospective cohort study
por: Tupikowski, Krzysztof, et al.
Publicado: (2021)

Deregulation of the spindle assembly checkpoint is associated with paclitaxel resistance in ovarian cancer
por: Chong, Taryne, et al.
Publicado: (2018)

Checkpoint Inhibition in Myeloma: Opportunities and Challenges
por: Costa, Federica, et al.
Publicado: (2018)

Deficient Spindle Assembly Checkpoint in Multiple Myeloma
por: Díaz-Rodríguez, Elena, et al.
Publicado: (2011)

Immune checkpoint inhibitors for multiple myeloma immunotherapy
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Endothelial Function in Patients with Hematologic Malignancies Undergoing High-Dose Chemotherapy Followed by Hematopoietic Stem Cell Transplantation
por: Poręba, Małgorzata, et al.
Publicado: (2015)

Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer
por: Zaravinos, Apostolos, et al.
Publicado: (2019)

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2016)

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Karabon, Lidia, et al.
Publicado: (2018)

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2017)

Checkpoint inhibitors and myeloma: promises, deadlocks and new directions
por: Bertamini, Luca, et al.
Publicado: (2020)

Evaluation of the impact of treatment with hematopoietic stem cells transplantation (HSCT) on biochemical markers of heart function and novel electrocardiographic markers of repolarization in patients with hematological malignancies
por: Poręba, Małgorzata, et al.
Publicado: (2018)

Immune Checkpoint Molecules—Inherited Variations as Markers for Cancer Risk
por: Wagner, Marta, et al.
Publicado: (2021)

Differential Function of a Novel Population of the CD19+CD24hiCD38hi Bregs in Psoriasis and Multiple Myeloma
por: Bartosińska, Joanna, et al.
Publicado: (2021)

Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises
por: Alkharabsheh, Omar, et al.
Publicado: (2021)

Deregulation of HMGA1 expression induces chromosome instability through regulation of spindle assembly checkpoint genes
por: Pierantoni, Giovanna Maria, et al.
Publicado: (2015)

Patterns of cell cycle checkpoint deregulation associated with intrinsic molecular subtypes of human breast cancer cells
por: Bower, Jacquelyn J., et al.
Publicado: (2017)

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma
por: Herrero, Ana B., et al.
Publicado: (2016)

Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation
por: Frydecka, Dorota, et al.
Publicado: (2014)

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia
por: Frydecka, Dorota, et al.
Publicado: (2015)

Comparative proteomic profiling of refractory/relapsed multiple myeloma reveals biomarkers involved in resistance to bortezomib-based therapy
por: Dytfeld, Dominik, et al.
Publicado: (2016)

Circulating immune checkpoints predict heart failure outcomes
por: Screever, Elles M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j9i96jd6mtr68lrljhr4h1n3gj